As TOR overactivation gives identical phenotype to complex I downregulation, future studies should investigate if our results may be relevant outside of the mitochondria field, in some of the other contexts involving TOR overactivation, such as many types of cancer, wound healing or aging, with potentially important clinical implications. Here, RORC is linked to cancer.